Patent · US Active

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

US12365688B2 · kind B2 · utility

0Cited by
12References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 10, 2023
Grant dateJul 22, 2025
Priority date—
Expiry dateJul 10, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to inhibitors of SHP2 having the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.